Pediatric Bacterial Endocarditis Clinical Presentation
- Author: Michael H Gewitz, MD; Chief Editor: P Syamasundar Rao, MD more...
Patients with acute bacterial endocarditis (ABE) present with an acute, toxic, febrile illness and symptoms that have lasted less than 2 weeks. (Between 85% and 99% of patients are febrile.) Often, the heart is structurally normal before ABE onset.
Features in the patient’s history can include fatigue, chills, sweats, anorexia, malaise, cough, headache, myalgia and/or arthralgia, and confusion.
A history of intravenous (IV) drug use may be elicited, as it was in the patient whose chest x-ray is below.
Patients with congenital heart disease and fever require special consideration.
Patients with subacute bacterial endocarditis (SBE) present with a more nonspecific, flulike illness and symptoms that may have lasted more than 2 weeks. Subacute bacterial endocarditis is more common in patients with an underlying congenital heart defect. Clinical findings are related to four underlying phenomena, namely, bacteremia (or fungemia), valvulitis, immunologic responses, and/or emboli.
Physical findings are nonspecific and vary. Factors such as the duration of illness, microbiologic etiology, and patient's age may vary. Thus, the frequency with which different signs and symptoms are manifested is variable. One study that analyzed 76 consecutive cases revealed the following prevalences: fever, 99%; petechiae, 21%; changing murmur, 21%; hepatosplenomegaly, 14%; congestive heart failure, 9%; splenomegaly, 7%; splinter hemorrhages, 5%; retinal hemorrhages (Roth spots), 5%; Osler nodes, 4%; and arthritis, 3%.
As previously mentioned, fever is present in 85-99% of patients with endocarditis. The fever is usually low grade, with a temperature rarely exceeding 39°C that is remittent and is typically not associated with rigors.
A new or changing heart murmur is noted in many patients. These murmurs may be difficult to identify in patients with subacute endocarditis or in infants and young children who may already have a clinically significant murmur secondary to congenital heart disease.
Peripheral signs may be observed, although extracardiac manifestations of endocarditis are less common overall in children than in adults. Petechiae are the most common of these signs (20-40%). They are found on the palpebral conjunctiva, the buccal or palatal mucosa, and the extremities. However, petechiae are not specific for endocarditis.
Splenomegaly is a common finding on abdominal examinations.
Splinter and subungual hemorrhages are dark red, linear streaks in the nail beds of the fingers and toes. Osler nodes are small, tender, subcutaneous nodules that develop in the pulp of the digits.
Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005 Jun 14. 111(23):e394-434. [Medline].
Pasquali SK, He X, Mohamad Z, McCrindle BW, Newburger JW, Li JS, et al. Trends in endocarditis hospitalizations at US children's hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines. Am Heart J. 2012 May. 163(5):894-9. [Medline]. [Full Text].
Johnson JA, Boyce TG, Cetta F, Steckelberg JM, Johnson JN. Infective endocarditis in the pediatric patient: a 60-year single-institution review. Mayo Clin Proc. 2012 Jul. 87(7):629-35. [Medline]. [Full Text].
Ware AL, Tani LY, Weng HY, Wilkes J, Menon SC. Resource utilization and outcomes of infective endocarditis in children. J Pediatr. 2014 Oct. 165 (4):807-12.e1. [Medline].
Russell HM, Johnson SL, Wurlitzer KC, Backer CL. Outcomes of surgical therapy for infective endocarditis in a pediatric population: a 21-year review. Ann Thorac Surg. 2013 Jul. 96(1):171-4: discussion 174-5. [Medline].
Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007 Oct 9. 116(15):1736-54. [Medline].
Martin JM, Neches WH, Wald ER. Infective endocarditis: 35 years of experience at a children's hospital. Clin Infect Dis. 1997 Apr. 24 (4):669-75. [Medline].
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000 Apr. 30(4):633-8. [Medline].
Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009 Mar 24. 119(11):1541-51. [Medline].
Baltimore RS, Gewitz M, Baddour LM, et al, for the American Heart Association Rheumatic Fever, Endocarditis, et al. infective endocarditis in childhood: 2015 update: a scientific statement from the American Heart Association. Circulation. 2015 Oct 13. 132 (15):1487-515. [Medline].
Nichols KR, Israel EN, Thomas CA, Knoderer CA. Optimizing guideline-recommended antibiotic doses for pediatric infective endocarditis. Ann Pharmacother. 2016 Feb 25. [Medline].
Patel J, Kupferman F, Rapaport S, Kern JH. Preprocedure prophylaxis against endocarditis among United States pediatric cardiologists. Pediatr Cardiol. 2014 Oct. 35 (7):1220-4. [Medline].
Thornhill MH, Dayer MJ, Forde JM, et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ. 2011 May 3. 342:d2392. [Medline]. [Full Text].